首页> 外文期刊>Journal of Kermanshah University of Medical Sciences >Goiter prevalence in Kermanshahian primary school children, 9 years after Iodine salt consumption (2001)
【24h】

Goiter prevalence in Kermanshahian primary school children, 9 years after Iodine salt consumption (2001)

机译:食用碘盐9年后,克尔曼沙罕小学儿童的甲状腺肿患病率(2001年)

获取原文
           

摘要

Background & Objectives: Iodine Deficiency Disorder (IDD) is the most common endocrine disorder in the world. It is estimated that about 1.5 billion people are in iodine deficiency state. Many studies have shown the high prevalence of endemic goiter and iodine deficiency in Iran. For control of this health problem salt iodinization is the best accepted strategy in the world. The main objective of this study is to determine the efficacy of iodide salt after 9 years of iodide salt consumption. Materials and methods: In a quasi-experimental study 637 primary school children were examined clinically for goiter based on WHO classification, and their urine was evaluated for iodine per gram creatinine. Results: 94 students (14.7%) including 50 males (15.38%) and 44 females (14.1%) had goiter, with no significant difference between two sexes. The most common grade of goiter was 1a. Compared with a previous report in 1992, there was no significant increase in goiter prevalence but increase in urine iodine was statistically significant (P<0001). Discussion : Despite increase in urine iodine concentration, the rate of goiter is not decreased. It seems that salt iodinization and iodine consumption should be increased.
机译:背景与目的:碘缺乏症(IDD)是世界上最常见的内分泌疾病。据估计约有15亿人处于碘缺乏状态。许多研究表明伊朗的地方性甲状腺肿和碘缺乏症患病率很高。为了控制这一健康问题,盐碘化是世界上公认的最佳策略。这项研究的主要目的是确定碘盐食用9年后的碘盐疗效。材料和方法:在一项准实验研究中,根据WHO的分类标准,对637名小学生的甲状腺肿进行了临床检查,并对他们的尿液中每克肌酐的碘含量进行了评估。结果:94名学生(14.7%)患甲状腺肿,其中男50例(15.38%),女44例(14.1%),性别差异无统计学意义。甲状腺肿最常见的等级是1a。与1992年的以前的报告相比,甲状腺肿的患病率没有显着增加,但尿碘的增加有统计学意义(P <0001)。讨论:尽管尿碘浓度增加,但甲状腺肿的发生率并未降低。似乎应增加食盐碘化和碘的消耗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号